Identifying suppressive factors of Alzheimer’s disease through comprehensive analysis of real-world data: a single-center retrospective study

Abstract Background In addition to conventional symptomatic treatment drugs, anti-amyloid beta antibody drugs are expected to benefit patients with Alzheimer’s disease (AD). However, issues such as side effects and high costs persist, and new preventive and therapeutic drugs are desired. Meanwhile,...

Full description

Saved in:
Bibliographic Details
Main Authors: Mana Shiotani, Yuki Hyohdoh, Yutaka Hatakeyama, Hiroaki Kazui, Yoshiyasu Okuhara
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Geriatrics
Subjects:
Online Access:https://doi.org/10.1186/s12877-025-05982-x
Tags: Add Tag
No Tags, Be the first to tag this record!